The clinical management of patients with HLRCC requires an integrated, multidisciplinary approach. Diagnostic evaluation of individuals who are suspected of having HLRCC includes a thorough ...
Germline mutations in a gene that encodes a Krebs cycle enzyme have been found to result in a distinct clinical entity referred to as hereditary leiomyomatosis and renal cell cancer (HLRCC).